NEORX CORP
S-3, EX-23.1, 2000-09-08
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NEORX CORP, S-3, EX-5.1, 2000-09-08
Next: MAXUS INCOME FUND, N-30D, 2000-09-08



<PAGE>   1
                                                                    Exhibit 23.1

               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


The Board of Directors
NeoRx Corporation:

        We consent to the use of our report incorporated herein by reference and
to the reference to our firm under the heading "Experts" in the prospectus.



                                            /s/ KPMG LLP
                                            -------------------------------
                                            KPMG LLP

Seattle, Washington

September 7, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission